Genetic Variants Associated With the Risk of Gall Stones and Cirrhosis.
1 other identifier
observational
50
1 country
1
Brief Summary
Gall stone disease is more common in patients with cirrhosis. This association has been well established in different studies. Among the various factors which predispose a patient with gall stone disease to have associated liver cirrhosis, genetics also plays an important role. This study aims to do a genetic panel-based analysis of genes which are involved in cholestasis to find any association between liver cirrhosis and gall stone disease. Patients with history of gall stone or history of cholecystectomy done for gall stone disease will be evaluated for the presence of liver cirrhosis by fibroscan and ultrasonography. Those patients with cirrhosis and without cirrhosis will undergo a panel based genetic test for the common cholestasis genes and multivariate analysis will be done for variants associated with lithogenesis and cirrhosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 6, 2024
CompletedFirst Posted
Study publicly available on registry
November 7, 2024
CompletedStudy Start
First participant enrolled
November 10, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedNovember 7, 2024
November 1, 2024
1.1 years
November 6, 2024
November 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Identification of genetic risk-variants associated with both GS and modulation of liver cirrhosis in patients with cirrhosis.
Day 0
Secondary Outcomes (3)
Identification of genetic polymorphisms in bile-acid metabolism and enterohepatic circulation, associated with increased GS risk in patients with cirrhosis.
Day 0
Identification of genetic polymorphisms in cholesterol metabolism pathway, associated with increased GS risk in patients with cirrhosis.
Day 0
To study the association of UGT1A1 polymorphisms affecting bilirubin conjugation, with risk of GS in patients with cirrhosis.
Day 0
Study Arms (5)
Cirrhosis with GSD
Cirrhosis with GSD
No cirrhosis with no GSD
No cirrhosis with no GSD
Cirrhosis with no GSD
Cirrhosis with no GSD
GSD with no cirrhosis
GSD with no cirrhosis
Cirrhosis with history of cholecystectomy for GSD
Cirrhosis with history of cholecystectomy for GSD
Eligibility Criteria
* Patients \> 18 years of age. * Who have either gall stone disease or cirrhosis.
You may qualify if:
- Patients \> 18 years of age.
- Who has a GSD diagnosed by USG or have history of cholecystectomy for gall stone disease.
- Who is a diagnosed case of cirrhosis by Fibroscan or USG (Cirrhosis including alcohol related cirrhosis, Hepatitis B, Hepatitis C, Wilsons disease, Hemochromatosis are excluded.
You may not qualify if:
- Patients who have haemolytic anaemia
- Patients who do not consent for genetic study
- Patients who has a diagnosed cause for liver disease, including alcohol related cirrhosis, Hepatitis B, Hepatitis C, Wilsons disease, Hemochromatosis.
- Inability to provide informed consent.
- Cannot understand Hindi or English should be excluded since they will not be able to reply objectively to questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Liver & Biliary Sciences
New Delhi, National Capital Territory of Delhi, 110070, India
Biospecimen
Genetic Analysis
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 6, 2024
First Posted
November 7, 2024
Study Start
November 10, 2024
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
November 7, 2024
Record last verified: 2024-11